$10.80 -0.15 (-1.37%)
11/6/2009 4:02 PM

Harte-Hanks, Inc. (HHS)

CAPS Rating: 2 out of 5

A direct and targeted marketing company that provides direct marketing services to a range of local, regional, national and international consumer and business-to-business marketers.

Current Price $10.80 Mkt Cap $686.59M
Open $10.78 P/E Ratio 14.41
Prev. Close $10.95 Div. (Yield) 0.30 (2.70%)
Daily Range $10.62 - $11.05 Volume 388,290
52-Wk Range $4.43 - $14.48 Avg. Daily Vol. 294,000

HHS News and Commentary

Caps

How do you think HHS will perform vs the S&P 500?

Add Stock to Watchlist

All Members

47 Outperform
18 Underperform
 

All-Star Members

26 Outperform
6 Underperform
 

Wall Street

2 Outperform
4 Underperform
 

Top HHS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

notzia (76.32)
Submitted May 28, 2009

The analysis presented is based on a current price of $6.92.

The most concerning aspect of this stock is that the EPS is not growing much; for the 2001-2006 period, the compounded annual growth (CAGR) has been 11%, but extend the period to… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

HHS VS S&P 500 (SPY)

Fools bullish on HHS are also bullish on:

Recent Community Commentary

Read the most recent pitches from members about HHS.

Recs

2
Member Avatar notzia (76.32) Submitted: 5/28/2009 1:49:43 PM : Outperform Start Price: $6.88 HHS Score: +33.28

The analysis presented is based on a current price of $6.92.

The most concerning aspect of this stock is that the EPS is not growing much; for the 2001-2006 period, the compounded annual growth (CAGR) has been 11%, but extend the period to 2008 and CAGR drops to 3%. Nonetheless, the return on equity (ROE) has exceeded 15% since 2002 (exceeding 20% in 2005, 2006, and 2007), and the free cash flow has been positive since 2001 and generally increasing until 2007 and 2008.

Before I look at the valuations, I look at three indicators of financial safety. For this stock, all three are quite good. The Altman Z is 4.1; below 1.8 is risky, above 3 is the safe range. The Piotroski F is 6; 2 or below indicates caution, while 8 or 9 indicates that the stock is expected to rise within the next year. The Sloan accrual is -6.31; 5 or higher is high risk, while -5 or lower is excellent.

I use more than one valuation method to gauge intrinsic value; the first three all provide a good margin of safety (MOS). The first three are standards in the valuation literature. The estimate based on Graham’s formula was $18.45 (55% MOS), though if I increase the growth from 3% to 11% based on the discussion above, the estimate becomes $37 with an 81% MOS. The Earnings Power Value (value of the firm) was estimated, on a per share bases, to be $23 (70% MOS). The Discounted Cash Flow estimate valued the stock at $40 (83% MOS).

The last two were based on a spreadsheet found on the AAII website; these are designed to mimic Buffett’s valuation methodology. One is based on projecting EPS growth 10 years into the future based on past EPS growth; I discount the resulting valuation to reflect the price at which the stock will realize a compounded earnings (including dividends when applicable) return of 15%. The results of this method, even when the EPS growth is increased to 11%, do not recommend purchase of this stock.

The second is based on estimating EPS growth through the sustainable growth rate. The per-share projected book value is estimated by taking the previous year’s book value, adding EPS and subtracting dividends (when applicable). The projected EPS is estimated by multiplying the projected book value by the average Return on Equity, and the projected dividend is estimated by multiplying the projected EPS by the average payout ratio. I then discount the resulting valuation to reflect the price at which the stock will realize a compounded earnings return of 15%. Based on this method the target purchase needs to be below $7, and at the current price there is an 3% MOS

To ascertain that the price is attractive to me, I take one more thing into consideration. At the current price, would I expect an immediate 15% return on my investment (ROI) based on earnings and dividends? In this, the EPS represents about 14.2% of the share price by itself, so the 4.3% dividend yield is needed. However, because the dividend was needed to achieve the desired 15%, I also consider the risk that the dividend may be cut. This risk is assessed by evaluating several factors (Current Price, Current Yield, Current Payout Factor, Gross Margin, Operating Margin, Financial Leverage, EPS Growth). Based on this assessment, there is a moderate (most recent fiscal year) to moderate (TTM) risk that the dividend may be cut. Although greater weight is given to a TTM assessment, there is still enough certainty that the dividend will still support a 15% ROI.

Because there are many stocks that meet all of my criteria, I will not actually invest in HHS at this time. However, for CAPS purposes, I feel that it will outperform the market as a whole and make a caveat-filled recommendation.

Recs

0
Member Avatar mailmaster1 (< 20) Submitted: 7/29/2008 3:02:52 PM : Outperform Start Price: $11.69 HHS Score: +4.26

I have been with HHS for 19 years and it has been a solid company year in and year out. They have taken a beating this past year but you can't keep a good company down. She's coming back and I want a boatload of shares before she does.

Recs

0
Member Avatar K2mission (< 20) Submitted: 2/26/2008 3:02:18 PM : Outperform Start Price: $16.83 HHS Score: -16.38

After things pan out with the California and Florida advertising publications (PennySaver.com and theFlyer.com, respectively), things should get back on track. Harte Hanks has shown great prowess in their marketing endeavors and have the skills and technology to leverage a companie's data to offer great returns.

Leaderboard

Find the members with the highest scoring picks in HHS.

Score Leader

ringmaster9947

ringmaster9947 (96.40) Score: +97.97

The Score Leader is the member with the highest score across all their picks in HHS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
ringmaster9947 96.40 11/19/2008 Outperform 1Y $4.78 +125.90% +27.93% +97.97
bhayek 98.39 12/23/2008 Outperform NS $5.80 +86.35% +24.56% +61.79
SavantTheIdiot 99.08 2/23/2009 Outperform NS $5.48 +96.94% +39.30% +57.64
PurpleRoyalty09 69.31 4/2/2009 Outperform NS $5.86 +84.40% +29.77% +54.63
goodbar2k 98.79 10/22/2008 Outperform 1Y $6.39 +69.09% +21.35% +47.74
HummaKavula 99.75 4/20/2009 Outperform NS $6.66 +62.27% +26.54% +35.73
3st1 95.23 1/9/2009 Outperform NS $6.98 +54.64% +19.60% +35.04
notzia 76.32 4/17/2009 Outperform 3Y $6.88 +56.93% +23.64% +33.28 3 Comments
sjvbcl 71.02 5/16/2007 Underperform 3W $23.98 -54.96% -24.90% +30.06
schwah9 97.26 10/13/2008 Outperform NS $7.74 +39.47% +16.34% +23.13

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBMOCapital 86.09 9/4/2009 Underperform NS $11.85 -8.86% +7.21% +16.08
TrackJimCramer < 20 8/1/2008 Underperform 3W $11.93 -9.48% -12.38% -2.90
TrackRichPzena < 20 6/17/2008 Outperform 1Y $12.51 -13.70% -18.86% +5.16 1 Comment
TrackDeutscheSec 89.50 1/2/2008 Underperform NS $17.01 -21.33% -5.07% +16.26 4/25/2008 @ $13.38
TrackJohnRogers < 20 9/30/2007 Outperform NS $19.52 -29.13% -7.56% -21.57 5/5/2008 @ $13.83 1 Comment
TrackRonBaron < 20 9/30/2007 Outperform NS $19.41 -29.95% -13.05% -16.90 3/31/2008 @ $13.59 1 Comment
TrackJPMorgan 78.71 9/18/2007 Underperform NS $21.15 -48.95% -24.23% +24.72
TrackMatrix 89.45 9/6/2007 Underperform NS $22.15 -51.25% -23.78% +27.47
TrackAGEdwards 89.12 1/3/2007 Outperform NS $26.63 -59.44% -20.06% -39.38
TrackJMP < 20 9/12/2006 Outperform NS $25.45 +4.13% +11.02% -6.89 2/1/2007 @ $26.50

Featured Broker Partners